share_log
Reuters ·  Dec 3, 2024 04:30
Accord Biopharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire Udenyca® (Pegfilgrastim-Cbqv) Business From Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment